Strikingly, our careful examination of each step of the heme biosynthetic pathway shows that the essentiality extent of either ALAS or FECH, which both code for the first and terminal enzymes of the heme biosynthetic pathway, respectively, did not differ significantly between the in vivo murine cancer models. The gene discussed is ALAS1; the disease is cancer.